Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Type 2 diabetes
Biotech
Lilly posts more positive data on once-weekly insulin prospect
Shortly after a positive data drop for Eli Lilly’s efsitora, the Indianapolis-based company is again padding the case for its weekly insulin prospect.
Fraiser Kansteiner
Sep 11, 2024 2:05pm
Lilly posts more positive data on its weekly insulin prospect
Sep 5, 2024 6:45am
Embecta's insulin patch pump secures FDA nod in Type 2 diabetes
Sep 3, 2024 2:29pm
ProKidney halts ph. 3 trial not needed for cell therapy approval
Sep 3, 2024 8:55am
Insulet nets first auto insulin pump OK in Type 2 diabetes
Aug 27, 2024 11:00am
Innovent bags another phase 3 win for next-gen Lilly GLP-1 drug
Jul 22, 2024 5:31am
